Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

St. Jude Medical's spinal cord stimulation system receives FDA approval


Friday, 4 Apr 2014 08:00am EDT 

St. Jude Medical Inc:Announces the approval of its Protege IPG from the U.S. Food and Drug Administration.Protege is the neurostimulation system that allows spinal cord stimulation (SCS) technology upgrades as they are approved to be made via software updates. 

Company Quote

67.76
-0.52 -0.76%
17 Apr 2015